OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma

被引:4
作者
Tan, Juntao [1 ]
Yu, Yue [2 ]
Lin, Xiantian [3 ]
He, Yuxin [4 ]
Jin, Wen [5 ]
Qian, Hong [6 ]
Li, Ying [7 ]
Xu, Xiaomei [8 ,9 ]
Zhao, Yuxi [3 ]
Ning, Jianwen [10 ]
Zhang, Zhengyu [5 ]
Chen, Jingjing [11 ]
Wu, Xiaoxin [3 ]
机构
[1] Chongqing Med Univ, Affiliated Banan Hosp, Operat Management Off, Chongqing 401320, Peoples R China
[2] Hlth Sci Mayo Clin, Sr Bioinformatician Dept Quantitat, Rochester, MN 55905 USA
[3] Zhejiang Univ, Affiliated Hosp 1, Natl Clin Res Ctr Infect Dis, State Key Lab Diag & Treatment Infect Dis,Sch Med, 79 Qing Chun Rd, Hangzhou 310003, Zhejiang, Peoples R China
[4] Chongqing Med Univ, Affiliated Banan Hosp, Dept Med Adm, Chongqing 401320, Peoples R China
[5] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Med Records Dept, Hangzhou 310003, Peoples R China
[6] Lanzhou Univ, Hosp 1, Med Records Dept, Lanzhou 730000, Peoples R China
[7] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Adm, Hangzhou 310003, Peoples R China
[8] Chengdu Fifth Peoples Hosp, Dept Gastroenterol, Chengdu 611130, Peoples R China
[9] Chongqing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Chongqing 404000, Peoples R China
[10] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Emergency Dept, Hangzhou 310003, Peoples R China
[11] Zhejiang Univ City Coll, Dept Digital Urban Governance, Hangzhou 310015, Peoples R China
关键词
Hepatocellular carcinoma; Survival duration; Nomogram; Risk stratification; Predictive model; EPIDEMIOLOGY; PROGNOSIS; CANCER; AFP; METASTASIS; DIAGNOSIS; SCORE; HCC;
D O I
10.1007/s12072-023-10516-x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Although the elderly constitute more than a third of hepatocellular carcinoma (HCC) patients, they have not been adequately represented in treatment and prognosis studies. Thus, there is not enough evidence to guide the treatment of such patients. The objective of this study is to identify the prognostic factors of older patients with HCC and to construct a new prognostic model for predicting their overall survival (OS). Methods 2,721 HCC patients aged >= 65 were extracted from the public database-Surveillance, Epidemiology, and End Results (SEER) and randomly divided into a training set and an internal validation set with a ratio of 7:3. 101 patients diagnosed from 2008 to 2017 in the First Affiliated Hospital of Zhejiang University School of Medicine were identified as the external validation set. Univariate cox regression analyses and multivariate cox regression analyses were adopted to identify these independent prognostic factors. A predictive nomogram-based risk stratification model was proposed and evaluated using area under the receiver operating characteristic curve (AUC), calibration curves, and a decision curve analysis (DCA). Results These attributes including age, sex, marital status, T stage, N stage, surgery, chemotherapy, tumor size, alphafetoprotein level, fibrosis score, bone metastasis, lung metastasis, and grade were the independent prognostic factors for older patients with HCC while predicting survival duration. We found that the nomogram provided a good assessment of OS at 1, 3, and 5 years in older patients with HCC (1-year OS: (training set: AUC = 0.823 (95%CI 0.803-0.845); internal validation set: AUC = 0.847 (95%CI 0.818-0.876); external validation set: AUC = 0.732 (95%CI 0.521-0.943)); 3-year OS: (training set: AUC = 0.813 (95%CI 0.790-0.837); internal validation set: AUC = 0.844 (95%CI 0.812-0.876); external validation set: AUC = 0.780 (95%CI 0.674-0.887)); 5-year OS: (training set: AUC = 0.839 (95%CI 0.806-0.872); internal validation set: AUC = 0.800 (95%CI 0.751-0.849); external validation set: AUC = 0.821 (95%CI 0.727-0.914)). The calibration curves showed that the nomogram was with strong calibration. The DCA indicated that the nomogram can be used as an effective tool in clinical practice. The risk stratification of all subgroups was statistically significant (p < 0.05). In the stratification analysis of surgery, larger resection (LR) achieved a better survival curve than local destruction (LD), but a worse one than segmental resection (SR) and liver transplantation (LT) (p < 0.0001). With the consideration of the friendship to clinicians, we further developed an online interface (OHCCPredictor) for such a predictive function (https://junta otan.shinyapps.io/dynnomapp_hcc/). With such an easily obtained online tool, clinicians will be provided helpful assistance in formulating personalized therapy to assess the prognosis of older patients with HCC. Conclusions Age, sex, marital status, T stage, N stage, surgery, chemotherapy, tumor size, AFP level, fibrosis score, bone metastasis, lung metastasis, and grade were independent prognostic factors for elderly patients with HCC. The constructed nomogram model based on the above factors could accurately predict the prognosis of such patients. Besides, the developed online web interface of the predictive model provide easily obtained access for clinicians.
引用
收藏
页码:550 / 567
页数:18
相关论文
共 47 条
[1]   NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization [J].
Adhoute, Xavier ;
Penaranda, Guillaume ;
Raoul, Jean Luc ;
Bollon, Emilie ;
Pol, Bernard ;
Letreut, Yves P. ;
Perrier, Herve ;
Bayle, Olivier ;
Monnet, Olivier ;
Beaurain, Patrick ;
Muller, Cyril ;
Hardwigsen, Jean ;
Lefolgoc, Gaelle ;
Castellani, Paul ;
Bronowicki, Jean P. ;
Bourliere, Marc .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (06) :706-715
[2]   Bone metastasis in hepatocellular carcinoma: Need for reappraisal of treatment [J].
Attili, V. Satya Suresh ;
Babu, K. Govind ;
Lokanatha, D. ;
Bapsy, P. P. ;
Ramachandra, C. ;
Rajshekar, H. .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2008, 4 (02) :93-94
[3]   The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma [J].
Bai, Dou-Sheng ;
Zhang, Chi ;
Chen, Ping ;
Jin, Sheng-Jie ;
Jiang, Guo-Qing .
SCIENTIFIC REPORTS, 2017, 7
[4]   Competing Risks in Older Patients With Cancer: A Systematic Review of Geriatric Oncology Trials [J].
Burdett, Nikki ;
Vincent, Andrew D. ;
O'Callaghan, Michael ;
Kichenadasse, Ganessan .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (08) :825-830
[5]   The efficacy of surgery in advanced hepatocellular carcinoma: a cohort study [J].
Chen, Lei ;
Sun, Tao ;
Chen, Shi ;
Ren, Yanqiao ;
Yang, Fan ;
Zheng, Chuansheng .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
[6]   Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].
Cheng, Ann-Lii ;
Kang, Yoon-Koo ;
Chen, Zhendong ;
Tsao, Chao-Jung ;
Qin, Shukui ;
Kim, Jun Suk ;
Luo, Rongcheng ;
Feng, Jifeng ;
Ye, Shenglong ;
Yang, Tsai-Sheng ;
Xu, Jianming ;
Sun, Yan ;
Liang, Houjie ;
Liu, Jiwei ;
Wang, Jiejun ;
Tak, Won Young ;
Pan, Hongming ;
Burock, Karin ;
Zou, Jessie ;
Voliotis, Dimitris ;
Guan, Zhongzhen .
LANCET ONCOLOGY, 2009, 10 (01) :25-34
[7]   Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database [J].
Ding, Jingli ;
Wen, Zhili .
BMC CANCER, 2021, 21 (01)
[8]   Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis [J].
El-Serag, Hashem B. ;
Rudolph, Lenhard .
GASTROENTEROLOGY, 2007, 132 (07) :2557-2576
[9]   A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database [J].
He, Taiyu ;
Chen, Tianyao ;
Liu, Xiaozhu ;
Zhang, Biqiong ;
Yue, Song ;
Cao, Junyi ;
Zhang, Gaoli .
FRONTIERS IN PUBLIC HEALTH, 2022, 9
[10]   AASLD guidelines for the treatment of hepatocellular carcinoma [J].
Heimbach, Julie K. ;
Kulik, Laura M. ;
Finn, Richard S. ;
Sirlin, Claude B. ;
Abecassis, Michael M. ;
Roberts, Lewis R. ;
Zhu, Andrew X. ;
Murad, M. Hassan ;
Marrero, Jorge A. .
HEPATOLOGY, 2018, 67 (01) :358-380